CLINICAL_TRIALS ClinicalTrials.gov record update

Substudy of the the CANTOS Trial (Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated Hs-CRP; CACZ885M2301)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01900600
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:07.684399+00:00
Published At: 2018-10-10T00:00:00+00:00
Record Updated At: 2018-10-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Prior Acute Myocardial Infarction", "Evidence of Systemic Inflammation (C Reactive Protein Plasma \u003e2 mg/l)", "Reduced Left Ventricle Ejection Fraction (\u003c50%)", "Symptoms of Heart Failure (NYHA Class II-III)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-10-10"
protocolSection.identificationModule.nctId: "NCT01900600"
protocolSection.identificationModule.officialTitle: "Substudy of the the CANTOS Trial (Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated Hs-CRP; CACZ885M2301)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.